Holistic health record for Hidradenitis suppurativa patients

Hidradenitis suppurativa (HS) is a recurrent inflammatory skin disease with a complex etiopathogenesis whose treatment poses a challenge in the clinical practice. Here, we present a novel integrated pipeline produced by the European consortium BATMAN (Biomolecular Analysis for Tailored Medicine in A...

Full description

Saved in:
Bibliographic Details
Published in:Scientific reports 2022-05, Vol.12 (1), p.8415-8415, Article 8415
Main Authors: Tricarico, Paola Maura, Moltrasio, Chiara, Gradišek, Anton, Marzano, Angelo V, Flacher, Vincent, Boufenghour, Wacym, von Stebut, Esther, Schmuth, Matthias, Jaschke, Wolfram, Gams, Matjaž, Boniotto, Michele, Crovella, Sergio
Format: Article
Language:English
Subjects:
631/208
631/250
631/337
631/532
692/308
692/420
692/699
692/700
Acne
Cell culture
Consortia
Dermatology
Diagnosis
Epithelial cells
Genetic diversity
Genetic variance
Human health and pathology
Humanities and Social Sciences
Immunology
Integrated approach
Life Sciences
Molecular modelling
multidisciplinary
Patients
Science
Science (multidisciplinary)
Skin diseases
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hidradenitis suppurativa (HS) is a recurrent inflammatory skin disease with a complex etiopathogenesis whose treatment poses a challenge in the clinical practice. Here, we present a novel integrated pipeline produced by the European consortium BATMAN (Biomolecular Analysis for Tailored Medicine in Acne iNversa) aimed at investigating the molecular pathways involved in HS by developing new diagnosis algorithms and building cellular models to pave the way for personalized treatments. The objectives of our european Consortium are the following: (1) identify genetic variants and alterations in biological pathways associated with HS susceptibility, severity and response to treatment; (2) design in vitro two-dimensional epithelial cell and tri-dimensional skin models to unravel the HS molecular mechanisms; and (3) produce holistic health records HHR to complement medical observations by developing a smartphone application to monitor patients remotely. Dermatologists, geneticists, immunologists, molecular cell biologists, and computer science experts constitute the BATMAN consortium. Using a highly integrated approach, the BATMAN international team will identify novel biomarkers for HS diagnosis and generate new biological and technological tools to be used by the clinical community to assess HS severity, choose the most suitable therapy and follow the outcome.
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-022-11910-5